Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shiva Shirani-Bidabadi
Institution:
Isfahan University of Medical Sciences
Observed institution:
Isfahan University of Medical Sciences
ORCID:
0000-0002-4735-9219
Observed ORCID:
0000-0002-4735-9219
OpenAlex ID:
A5028603604
CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer
2023
·
Shiva Shirani-Bidabadi
, Aliye Tabatabaee
, et al.
·
European Journal of Cell Biology
·
18
Gene network analysis of oxaliplatin-resistant colorectal cancer to target a crucial gene using chitosan/hyaluronic acid/protamine polyplexes containing CRISPR-Cas9
2023
·
Shiva Shirani-Bidabadi
, Mina Mirian
, et al.
·
Biochimica et Biophysica Acta (BBA) - General Subjects
·
16
Fabrication and evaluation of a dual-targeting nanoparticle mediated CRISPR/Cas9 delivery to combat drug resistance in breast cancer cells
2023
·
Nazita Tavazohi
, Mina Mirian
, et al.
·
Journal of Drug Delivery Science and Technology
·
8
Toward mechanism-informed IVIVC in non-viral gene delivery: From nanoparticle transformation to therapeutic action
2026
·
Mina Vaezi
, Robabehbeygom Ghafelehbashi
, et al.
·
Advanced Drug Delivery Reviews
Exploring the Role of Alpinia officinarum against Acute Myeloid Leukemia using Network Pharmacology, Molecular Docking and Molecular Dynamics Simulation
2025
·
Shiva Shirani-Bidabadi
, Shahram Nekoeian
, et al.
·
Journal of Computational Biophysics and Chemistry
Show more works
View as search
Works count:
5
Citation count:
42
H-index:
3
I10-index:
2
Year
Topic
Type